Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Thyroid Neoplasms × nintedanib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Thyroid Neoplasms 1 Sarcoma 1 Neoplasm Metastasis 1 Mesothelioma, Malignant 1 Endometrial Adenocarcinoma 1 Carcinoma, Medullary 1

Interventions

vandetanib 1 tumor necrosis factor-alpha, CNGRC fusion protein, human 1 nintedanib 1 mercaptoundecahydrododecaborate 1 Surveys and Questionnaires 1 Docetaxel 1 4-boronophenylalanine-fructose 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01788982 2020-07-31

Nintedanib(BIBF1120) in Thyroid Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed

Thyroid Neoplasms, Carcinoma, Medullary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡